These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10357643)

  • 1. The peritoneal immune system and continuous ambulatory peritoneal dialysis.
    Rapoport J; Hausmann MJ; Chaimovitz C
    Nephron; 1999; 81(4):373-80. PubMed ID: 10357643
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritoneal macrophage and lymphocyte cytoplasmic Ca2+: effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Santoni O; Schelotto C; Caviglia PM
    Perit Dial Int; 1993; 13 Suppl 2():S286-90. PubMed ID: 8399590
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.
    Topley N; Williams JD
    Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045
    [No Abstract]   [Full Text] [Related]  

  • 4. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
    Cameron JS
    Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal immune defense in continuous ambulatory peritoneal dialysis: clinical relevance and practical implications.
    Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S278-81. PubMed ID: 8399588
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity.
    Topley N; Mackenzie R; Jörres A; Coles GA; Davies M; Williams JD
    Perit Dial Int; 1993; 13 Suppl 2():S282-5. PubMed ID: 8399589
    [No Abstract]   [Full Text] [Related]  

  • 7. Peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients dialyzed exclusively with lactate-buffered dialysate.
    Daugirdas JT; Gandhi VC; McShane AP; Leehey DJ; Chan AY; Jablokow VR; Ing TS
    Int J Artif Organs; 1986 Nov; 9(6):413-6. PubMed ID: 3818115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host defense mechanisms involved in peritonitis.
    Lewis SL; Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S295-8. PubMed ID: 8399592
    [No Abstract]   [Full Text] [Related]  

  • 9. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal function and peritonitis in patients on peritoneal dialysis.
    Friedlander M
    J Lab Clin Med; 1993 Dec; 122(6):639-40. PubMed ID: 8245682
    [No Abstract]   [Full Text] [Related]  

  • 11. Peritoneal host defense mechanisms.
    Holmes CJ
    Perit Dial Int; 1996; 16 Suppl 1():S124-5. PubMed ID: 8728177
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The quality of the peritoneum in continuous ambulatory peritoneal dialysis].
    Krediet RT; Boeschoten EW; Arisz L
    Ned Tijdschr Geneeskd; 1986 Jan; 130(3):110-3. PubMed ID: 3951598
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging features of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.
    Ti JP; Al-Aradi A; Conlon PJ; Lee MJ; Morrin MM
    AJR Am J Roentgenol; 2010 Jul; 195(1):W50-4. PubMed ID: 20566781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of peripheral and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
    Lewis SL; Kutvirt SG; Cooper CL; Bonner PN; Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S273-7. PubMed ID: 8399587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of gastrointestinal function after renal transplantation in patients with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.
    Bhandari S
    Am J Kidney Dis; 1996 Apr; 27(4):604. PubMed ID: 8678075
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.
    Liao CT; Andrews R; Wallace LE; Khan MW; Kift-Morgan A; Topley N; Fraser DJ; Taylor PR
    Kidney Int; 2017 May; 91(5):1088-1103. PubMed ID: 28065517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal host defense mechanisms in peritoneal dialysis.
    Holmes CJ
    Kidney Int Suppl; 1994 Dec; 48():S58-70. PubMed ID: 7700043
    [No Abstract]   [Full Text] [Related]  

  • 20. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
    Fine RN; Salusky IB; Hall T; Lucullo L; Jordan SC; Ettenger RB
    Pediatrics; 1983 May; 71(5):806-9. PubMed ID: 6835766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.